This agreement has nothing to do with us. It shows we're not their only customer and that's not interesting or surprising.
We're moving forward on non-distal IBD, which is good. Our management is confident in getting the B-UP. Hopefully the prospective partner already has the inert foam/gel technology so we can get into clinical trials quickly. Sounds like we could get a Phase 2/3 IBD trial simultaneously, though likely un-partnered.